Experience of remote monitoring of treatment quality in patients with arterial hypertension during the current pandemic period

Abstract

Objective. To conduct a retrospective assessment of the dynamics of blood pressure (BP), the quality of antihypertensive therapy and the frequency of contacts with doctors in conditions of pandemic among patients with hypertension identified during a preventive examination of the population in an organized population of Baku.

Materials and methods. Two groups of patients were studied: group 1 – patients with hypertension who were aware of their disease before the start of the preventive examination; group 2 – patients who were diagnosed hypertension for the first time during the preventive examination. The results of the survey of these patients according to the questionnaire by means of telephone contacts, which includes questions regarding the control of blood pressure (BP), taking antihypertensive drugs, frequency of visiting doctors for 2 years after the initial preventive examination were studied.

Results. The results, obtained in group 1, indicate that taking antihypertensive drugs without periodic medical control over the effectiveness of therapy in most cases does not allow achieving the target values of blood pressure. The results, obtained in group 2, demonstrate poor adherence of patients to medical recommendations and justify the need to create a system of active detection and monitoring of persons with hypertension, who do not know about their disease.

Conclusions. It is necessary to create such a system of remote monitoring of newly identified and registered patients with hypertension, which based on modern technological advances, would allow patients to contact doctors (including remote ones) with a calculated frequency, and thus would ensure regular monitoring of the quality of treatment and adherence to recommendations regarding the treatment and prevention of cardiovascular diseases.

Keywords

Arterial hypertension / prevention / antihypertensive therapy

References

[1] Korostovtseva L.S. Arterial'naya gipertenziya. Arterial hypertension 2020; 2: 124–132. DOI: 10.18705/1607-419X-2020-26-2-124-132 PDF(RUS) (in Russian).

[2] Коростовцева Л.С. COVID-19: каковы риски пациентов с артериальной гипертензией? Артериальная гипертензия 2020; 2: 124–132. DOI: 10.18705/1607-419X-2020-26-2-124-132 PDF

[3] Mamedov M. Kardiovaskulyarnaya terapiya i profilaktika. Cardiovascular therapy and prevention 2021; 20(4): 2910. DOI: 10.15829/ 1728-8800-2021-20-4-2910 (in Russian).

[4] Мамедов М. Ведение пациентов во время коронавирусной пандемии и после нее. Кардиоваскулярная терапия и профилактика 2021; 20 (4): 2910.

[5] Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V. i dr. Kardiovaskulyarnaya terapiya i profilaktika. Cardiovascular therapy and prevention 2014; 13(6): 4–11 (in Russian).

[6] Муромцева Г.А., Концевая А.В., Константинов В.В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012–2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика 2014; 13 (6): 4–11.

[7] Global Burden of Disease Risk Factor Collaborators. Global, regional and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risk for 95 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1923–94.

[8] Global Burden of Disease Risk Factor Collaborators. Global, regional and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risk for 95 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1923–1994.

[9] Boitsov S.A., Balanova Yu.A., Shal'nova S.A. i dr. (51 avt) Kardiovaskulyarnaya terapiya i profilaktika. Cardiovascular therapy and prevention 2014; 13(4): 4–14. DOI: 10.15829/1728-8800-2014-4-4-14 (in Russian).

[10] Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25–64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика 2014; 13 (4): 4–14. DOI: 10.15829/1728-8800-2014-4-4-14.

[11] Shal'nova S.A., Balanova Yu.A., Konstantinov V.V., Kapustina A.V., Deev A.D. Ros. kardiol. zhurn. Ros. cardiol. journal 2006; 4(60): 45–50 (in Russian).

[12] Шальнова С.А., Баланова Ю.А., Константинов В.В., Тимофеева Т.Н., Иванов В.М., Капустина А.В., Деев А.Д. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Рос. кардиол. журн. 2006; 4 (60): 45–50.

[13] Mills K.T., Bunday J.D., Kelly T.N., Reed J.E., Kearney P.M., Reynolds K., Chen J., He J. Global disparities of hypertension prevalence and control: a systematic analysis of population – based studies from 90 countries. Circulation 2016; 134 (6): 441–50. DOI: 10.1161/CIRCULATIONAHA.115.018912.

[14] Mills K.T., Bunday J.D., Kelly T.N., Reed J.E., Kearney P.M., Reynolds K., Chen J., He J. Global disparities of hypertension prevalence and control: a systematic analysis of population – based studies from 90 countries. Circulation. 2016; 134 (6): 441–450. DOI: 10.1161/CIRCULATIONAHA.115.018912.

RIGHTS & PERMISSIONS

Eco-Vector